Aurinia Pharmaceuticals Inc.

AUPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001600620

SEC filings (opens in a new tab)

In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Aurinia Pharmaceuticals Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of AUPH: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	200	3	198	+1
Shares	50.3M	12.6K	50.9M	+537.0K (+1.1%)
Value	$487.5M	$122.2K	$395.2M	−$92.2M (−18.9%)

3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AUPH in Q3 2023
Institution	Shares	Value	% of portfolio
Nuveen Asset Management, LLC	2,352,463	$18.3M	0.01%
Twinbeech Capital LP	145,345	$1.13M	0.02%
Qube Research & Technologies Ltd	71,378	$554.6K	0.00%
Graham Capital Management, L.P.	68,448	$531.8K	0.02%
Flputnam Investment Management Co	40,391	$313.8K	0.01%
CI Private Wealth, LLC	33,721	$262.0K	0.00%
Caption Management, LLC	33,200	$258.0K	0.03%
Walleye Trading LLC	29,256	$227.3K	0.01%
Marshall Wace, LLP	24,506	$190.4K	0.00%
Diametric Capital, LP	24,240	$188.3K	0.08%
SG Americas Securities, LLC	21,182	$165.0K	0.00%
Bayesian Capital Management, LP	19,400	$150.7K	0.02%
Harvest Management LLC	15,000	$116.5K	0.07%
Boothbay Fund Management, LLC	14,163	$110.0K	0.00%
Tudor Investment Corp Et Al	13,533	$105.2K	0.00%
Bridgefront Capital, LLC	12,812	$99.5K	0.07%
Pictet Asset Management Holding SA	12,415	$96.5K	0.00%
Private Portfolio Partners LLC	11,550	$89.7K	0.02%
DekaBank Deutsche Girozentrale	8,448	$65.0K	0.00%
Belvedere Trading LLC	2,292	$17.8K	0.00%
Steward Financial Group LLC	1,000	$7.00K	0.00%
Northwestern Mutual Wealth Management Co	374	$2.91K	0.00%
Russell Investments Group, Ltd.	224	$1.74K	0.00%
Riggs Asset Managment Co. Inc.	200	$1.55K	0.00%

Sold out (23)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of AUPH in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Point72 Asset Management, L.P.	544,720	$5.27M
Antara Capital LP	500,000	$4.84M
Liontrust Investment Partners LLP	421,000	$4.08M
Prudential Financial Inc	241,740	$2.34M
Gsa Capital Partners LLP	168,595	$1.63M
Brookfield Asset Management Inc.	150,633	$1.46M
Verition Fund Management LLC	65,500	$634.0K
Gotham Asset Management, LLC	39,733	$384.6K
Aigen Investment Management, LP	29,675	$287.3K
Cubist Systematic Strategies, LLC	25,038	$242.4K
American Century Companies Inc	24,807	$240.1K
Nebula Research & Development LLC	23,391	$226.4K
Squarepoint Ops LLC	22,941	$222.1K
Axq Capital, LP	19,100	$184.9K
Virtu Financial LLC	15,795	$153.0K
Prelude Capital Management, LLC	15,395	$149.0K
Visionary Wealth Advisors	12,700	$122.9K
Wolverine Trading, LLC	13,220	$121.1K
Shell Asset Management Co	9,965	$96.0K
Focused Wealth Management, Inc	5,000	$48.4K
FNY Investment Advisers, LLC	4,500	$43.0K
Fiduciary Alliance LLC	1,000	$9.68K
Centiva Capital, LP	316	$3.06K

Not filed for Q3 2023 yet (3)

Institutions that held Aurinia Pharmaceuticals Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AUPH in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	12,415	$120.2K
Piershale Financial Group, Inc.	150	$1.45K
Coastal Capital Group, Inc.	64	$620